BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17043480)

  • 1. Metabolic syndrome and ischemic heart disease in gout.
    Vázquez-Mellado J; García CG; Vázquez SG; Medrano G; Ornelas M; Alcocer L; Marquez A; Burgos-Vargas R
    J Clin Rheumatol; 2004 Jun; 10(3):105-9. PubMed ID: 17043480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
    Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
    J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First acute gout attacks commonly precede features of the metabolic syndrome.
    Hernández-Cuevas CB; Roque LH; Huerta-Sil G; Rojas-Serrano J; Escudero A; Perez LL; Collantes-Estevez E; Vázquez Mellado J
    J Clin Rheumatol; 2009 Mar; 15(2):65-7. PubMed ID: 19265347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study.
    Nabipour I; Amiri M; Imami SR; Jahfari SM; Shafeiae E; Nosrati A; Iranpour D; Soltanian AR
    Int J Cardiol; 2007 May; 118(1):48-53. PubMed ID: 16875744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum cholesterol levels and their relation to ischemic cardiopathy in patients with non-insulin-dependent diabetes].
    Rodríguez-Morán M; Guerrero-Romero F
    Salud Publica Mex; 1997; 39(5):420-6. PubMed ID: 9424723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglycerides, high-density lipoprotein cholesterol, and risk of ischemic heart disease: a view from the Copenhagen Male Study.
    Jeppesen J
    Metab Syndr Relat Disord; 2003 Mar; 1(1):33-53. PubMed ID: 18370624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
    Haddad FH; Mahafza SM
    Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome.
    Feinberg MS; Schwartz R; Tanne D; Fisman EZ; Hod H; Zahger D; Schwammethal E; Eldar M; Behar S; Tenenbaum A
    Am J Cardiol; 2007 Mar; 99(5):667-72. PubMed ID: 17317369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study.
    Lonati C; Morganti A; Comarella L; Mancia G; Zanchetti A;
    J Hypertens; 2008 Sep; 26(9):1801-8. PubMed ID: 18698215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and particularities of dyslipidaemia in subjects with coronary heart disease.
    Agoşton-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(4):341-7. PubMed ID: 18767409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.